Previous close | 19.48 |
Open | 19.55 |
Bid | 19.27 x 200 |
Ask | 19.32 x 100 |
Day's range | 19.16 - 19.77 |
52-week range | 18.61 - 30.52 |
Volume | |
Avg. volume | 673,876 |
Market cap | 1.45B |
Beta (5Y monthly) | 1.64 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.02 |
Earnings date | 07 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 30.83 |
SOUTH SAN FRANCISCO, Calif., April 22, 2024--Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the first quarter of 2024 after the close of market on Tuesday, May 7, 2024. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day.
SOUTH SAN FRANCISCO, Calif., April 22, 2024--New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance
SOUTH SAN FRANCISCO, Calif., April 16, 2024--Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024